These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1425 related articles for article (PubMed ID: 15328326)

  • 21. The phenotype of
    Niemeijer ND; Rijken JA; Eijkelenkamp K; van der Horst-Schrivers ANA; Kerstens MN; Tops CMJ; van Berkel A; Timmers HJLM; Kunst HPM; Leemans CR; Bisschop PH; Dreijerink KMA; van Dooren MF; Bayley JP; Pereira AM; Jansen JC; Hes FJ; Hensen EF; Corssmit EPM
    Eur J Endocrinol; 2017 Aug; 177(2):115-125. PubMed ID: 28490599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
    Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
    Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher risk of phaeochromocytoma/paraganglioma (Phaeo-Pgl) in SDHD than SDHB carriers: an Australian cohort study.
    Hong A; Shanahan M; Schenberg T; Inder W; MacIsaac R; James P; Sachithanandan N
    Intern Med J; 2019 Apr; 49(4):529-532. PubMed ID: 30957378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.
    Brouwers FM; Eisenhofer G; Tao JJ; Kant JA; Adams KT; Linehan WM; Pacak K
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4505-9. PubMed ID: 16912137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutation analysis of the SDHB and SDHD genes in pheochromocytomas and paragangliomas: identification of a novel nonsense mutation (Q168X) in the SDHB gene.
    Oishi Y; Nagai S; Yoshida M; Fujisawa S; Sazawa A; Shinohara N; Nonomura K; Matsuno K; Shimizu C
    Endocr J; 2010; 57(8):745-50. PubMed ID: 20505258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
    Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium.
    Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M
    J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No difference in phenotype of the main Dutch SDHD founder mutations.
    van Hulsteijn LT; den Dulk AC; Hes FJ; Bayley JP; Jansen JC; Corssmit EP
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):824-31. PubMed ID: 23586964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening of mutations in genes that predispose to hereditary paragangliomas and pheochromocytomas.
    Lefebvre S; Borson-Chazot F; Boutry-Kryza N; Wion N; Schillo F; Peix JL; Brunaud L; Finat A; Calender A; Giraud S
    Horm Metab Res; 2012 May; 44(5):334-8. PubMed ID: 22517554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial pheochromocytoma.
    Erlic Z; Neumann HP
    Hormones (Athens); 2009; 8(1):29-38. PubMed ID: 19269919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variant type is associated with disease characteristics in SDHB, SDHC and SDHD-linked phaeochromocytoma-paraganglioma.
    Bayley JP; Bausch B; Rijken JA; van Hulsteijn LT; Jansen JC; Ascher D; Pires DEV; Hes FJ; Hensen EF; Corssmit EPM; Devilee P; Neumann HPH
    J Med Genet; 2020 Feb; 57(2):96-103. PubMed ID: 31492822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.
    Burnichon N; Rohmer V; Amar L; Herman P; Leboulleux S; Darrouzet V; Niccoli P; Gaillard D; Chabrier G; Chabolle F; Coupier I; Thieblot P; Lecomte P; Bertherat J; Wion-Barbot N; Murat A; Venisse A; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP;
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2817-27. PubMed ID: 19454582
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas.
    Domingues R; Montalvão P; Magalhães M; Santos R; Duarte L; Bugalho MJ
    J Endocrinol Invest; 2012 Dec; 35(11):975-80. PubMed ID: 22293219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas.
    Timmers HJ; Kozupa A; Eisenhofer G; Raygada M; Adams KT; Solis D; Lenders JW; Pacak K
    J Clin Endocrinol Metab; 2007 Mar; 92(3):779-86. PubMed ID: 17200167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gross SDHB deletions in patients with paraganglioma detected by multiplex PCR: a possible hot spot?
    Cascón A; Montero-Conde C; Ruiz-Llorente S; Mercadillo F; Letón R; Rodríguez-Antona C; Martínez-Delgado B; Delgado M; Díez A; Rovira A; Díaz JA; Robledo M
    Genes Chromosomes Cancer; 2006 Mar; 45(3):213-9. PubMed ID: 16258955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands.
    Hensen EF; van Duinen N; Jansen JC; Corssmit EP; Tops CM; Romijn JA; Vriends AH; van der Mey AG; Cornelisse CJ; Devilee P; Bayley JP
    Clin Genet; 2012 Mar; 81(3):284-8. PubMed ID: 21348866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL.EVA Investigators.
    Gimenez-Roqueplo AP; Caumont-Prim A; Houzard C; Hignette C; Hernigou A; Halimi P; Niccoli P; Leboulleux S; Amar L; Borson-Chazot F; Cardot-Bauters C; Delemer B; Chabolle F; Coupier I; Libé R; Peitzsch M; Peyrard S; Tenenbaum F; Plouin PF; Chatellier G; Rohmer V
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E162-73. PubMed ID: 23162105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
    Barletta JA; Hornick JL
    Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.
    Peczkowska M; Erlic Z; Hoffmann MM; Furmanek M; Cwikla J; Kubaszek A; Prejbisz A; Szutkowski Z; Kawecki A; Chojnowski K; Lewczuk A; Litwin M; Szyfter W; Walter MA; Sullivan M; Eng C; Januszewicz A; Neumann HP
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4818-25. PubMed ID: 18826997
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.